Aniracetam is another racetam nootropic, in the same family as the ever popular piracetam. It’s purported to be several factors stronger than piracetam, but slightly less potent than pramiractem. Much like pramiracetam, aniracetam is lipid soluble, so co-administration with a source of fat is crucial in ensuring maximum bio-availability of this nootropic.
Mechanism of Action
Aniracetam works in much the same way as other nootropics in the racetam family, by binding to glutamate receptors. This reinforces the neurotransmitter glutamate, promoting an increase in the quality of memory encoding, thus increasing learning capacity. It should be noted that the racetam family possess a variety of other mechanisms, as well as only having weak to moderate AMPA modulation.
•Boost learning and memory functions
•Demonstrates potential to heal both memory and reduced cognition caused by certain brain injuries (such as Alzhemier’s Disease)
•May have a slight stimulant effect
•May possess slight antidepressant qualities
Aniracetam is currently being used as a treatment for patients with Alzheimer’s Disease.
The recommended daily dose for aniracetam is around 3000mg. Higher dosing can result in some pretty distracting side effects: at twice as much as the RDA, there are intense feelings of nausea, as well as a persistent headache (lasting around a day), and a “clouding of the mind” similar to the effect of high strength cold medications. Staying within the 3000mg RDA is advisable.